TY - JOUR
T1 - Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls
T2 - A longitudinal ecological momentary assessment study
AU - Benedyk, Anastasia
AU - Moldavski, Alexander
AU - Reichert, Markus
AU - Reinhard, Iris
AU - Lohr, Sarah
AU - Schwarz, Kristina
AU - Berhe, Oksana
AU - Höflich, Anna
AU - Lautenbach, Sven
AU - von der Goltz, Christoph
AU - Ebner-Priemer, Ulrich
AU - Zipf, Alexander
AU - Tost, Heike
AU - Meyer-Lindenberg, Andreas
N1 - Publisher Copyright:
© 2023
PY - 2023/4
Y1 - 2023/4
N2 - The COVID-19 pandemic strongly impacted people's daily lives. However, it remains unknown how the pandemic situation affects daily-life experiences of individuals with preexisting severe mental illnesses (SMI). In this real-life longitudinal study, the acute onset of the COVID-19 pandemic in Germany did not cause the already low everyday well-being of patients with schizophrenia (SZ) or major depression (MDD) to decrease further. On the contrary, healthy participants’ well-being, anxiety, social isolation, and mobility worsened, especially in healthy individuals at risk for mental disorder, but remained above the levels seen in patients. Despite being stressful for healthy individuals at risk for mental disorder, the COVID-19 pandemic had little additional influence on daily-life well-being in psychiatric patients with SMI. This highlights the need for preventive action and targeted support of this vulnerable population.
AB - The COVID-19 pandemic strongly impacted people's daily lives. However, it remains unknown how the pandemic situation affects daily-life experiences of individuals with preexisting severe mental illnesses (SMI). In this real-life longitudinal study, the acute onset of the COVID-19 pandemic in Germany did not cause the already low everyday well-being of patients with schizophrenia (SZ) or major depression (MDD) to decrease further. On the contrary, healthy participants’ well-being, anxiety, social isolation, and mobility worsened, especially in healthy individuals at risk for mental disorder, but remained above the levels seen in patients. Despite being stressful for healthy individuals at risk for mental disorder, the COVID-19 pandemic had little additional influence on daily-life well-being in psychiatric patients with SMI. This highlights the need for preventive action and targeted support of this vulnerable population.
KW - COVID-19
KW - Depression
KW - Mental health risk
KW - Pandemic
KW - Schizophrenia
KW - Vulnerable population
UR - http://www.scopus.com/inward/record.url?scp=85147957300&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2023.01.008
DO - 10.1016/j.euroneuro.2023.01.008
M3 - Journal article
C2 - 36791492
AN - SCOPUS:85147957300
SN - 0924-977X
VL - 69
SP - 79
EP - 83
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
ER -